Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis

Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent

(2013) Masahiro Natsuaki et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

(2013) Pieter Cornelis Smits et al.   LANCET

Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly- l -Lactic Acid Coronary Stents

(2012) Soji Nishio et al.   CIRCULATION

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

(2012) G. G. Stefanini et al.   EUROPEAN HEART JOURNAL

Nobori Stent Shows Less Vascular Inflammation and Early Recovery of Endothelial Function Compared With Cypher Stent

(2012) Lakshmana K. Pendyala et al.   JACC-Cardiovascular Interventions

TCT-44 LEADERS: 5-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Biodegradable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer- Final report of the LEADERS study

(2012) Patrick Serruys et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Primary Endpoint Results of the EVOLVE Trial

(2012) Ian T. Meredith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bioresorbable Polymer Coated Drug Eluting Stent: A Model Study

(2012) Filippo Rossi et al.   MOLECULAR PHARMACEUTICS

Vascular responses to a biodegradable polymer (polylactic acid) based Biolimus A9-eluting stent in porcine models

(2012) Hitomi Hagiwara et al.   EuroIntervention

Randomized comparison of the nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries

(2011) Kazushige Kadota et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents

(2011) Xiaodong Ma et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Recent developments in drug-eluting stents

(2011) Yue Li et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

(2011) Giulio G Stefanini et al.   LANCET

The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study

(2010) Miodrag C. Ostojic et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

(2010) Lisette Jensen et al.   EuroIntervention

Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent Thrombosis

(2009) Stéphane Cook et al.   CIRCULATION

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study

(2008) Miodrag Ostojic et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients

(2008) Gaku Nakazawa et al.   CIRCULATION

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

(2008) Stephan Windecker et al.   LANCET